Biodesix Announces Fourth Quarter and Full Year 2020 Results
Full Year 2020 Revenue Growth of 86% on Record Revenue of approximately $46 million
BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. (NASDAQ: BDSX) a leading data-driven diagnostic solutions company with a focus in lung disease, today announced financi…